ArticleCancer chemotherapy and pharmacology2021

A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis.

Pawat Pattarawat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.